Fundraising Fox

Caris Life Sciences

NASDAQ: CAIUnicorn · $5.3B

Founded 1996 · Incorporated in Texas · 1,723 employees on LinkedIn · 10 known investors

Find your way into Caris Life Sciences

Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Caris Life Sciences was founded in 1996 by David Dean Halbert.

DDDavid Dean Halbert
David Dean HalbertChairman, Founder and CEO

Investors · 10

Coatue ManagementNew York · $1M – $20M
Silver Lake PartnersMenlo Park
Sixth StreetSan Francisco · $50M – $2.5B
BraidwellreportedStamford
Millennium ManagementreportedNew York
OrbiMedreportedNew York · $1M – $75M

Also in the syndicate · 4

First Light Asset ManagementGhisalloPerceptive AdvisorsWoodline

Funding

SEC filings, press & company announcements

$168M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Valuation · disclosed

Disclosed events
$5.3Bvaluation at IPOJun 2025 · $21.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Caris Life Sciences went on to found or lead other companies.

Harry SkigisSupport Engineer IIFounded Flat2VRJohn QuackenbushScientific Advisory Board MemberFounded GenoSpace

Competitors · 1

by search overlap
American Cancer Society (ACS)365 shared keywordsThe American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.

Companies competing with Caris Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

UBS Group Upgrades Caris Life Sciences (NASDAQ:CAI) to "Hold"marketbeat.com · Sep 2026Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detectfinance.yahoo.com · Sep 2026PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAImarketbeat.com · Aug 2026Maxi Investments CY Ltd Makes New $3.75 Million Investment in Caris Life Sciences, Inc. $CAImarketbeat.com · Aug 2026Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion - BioSpacebiospace.com · Apr 2025Caris Life Sciences closed growth capital funding round of $168 millioncarislifesciences.com · Apr 2025

Frequently asked questions

What does Caris Life Sciences do?
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.
Who founded Caris Life Sciences?
Caris Life Sciences was founded by David Dean Halbert in 1996.
Who are Caris Life Sciences's investors?
Caris Life Sciences's investors include Coatue Management, Silver Lake Partners, Sixth Street, Braidwell, Millennium Management, OrbiMed.
How much funding has Caris Life Sciences raised?
Caris Life Sciences has disclosed $168M raised across 1 round.